Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

MLA

Monika Rau, et al. “Prognostic Impact of Steatosis in the Clinical Course of Chronic HCV Infection—Results from the German Hepatitis C-Registry.” PLOS ONE, vol. 17, June 2022, p. e0264741. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a878fd1c5f24affa14d9e1d561e54e4a&authtype=sso&custid=ns315887.

APA

Monika Rau, Peter Buggisch, Stefan Mauss, Klaus H. W. Boeker, Hartwig Klinker, Tobias Müller, Albrecht Stoehr, Jörn M. Schattenberg, & Andreas Geier. (2022). Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry. PLOS ONE, 17, e0264741.

Chicago

Monika Rau, Peter Buggisch, Stefan Mauss, Klaus H. W. Boeker, Hartwig Klinker, Tobias Müller, Albrecht Stoehr, Jörn M. Schattenberg, and Andreas Geier. 2022. “Prognostic Impact of Steatosis in the Clinical Course of Chronic HCV Infection—Results from the German Hepatitis C-Registry.” PLOS ONE 17 (June): e0264741. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a878fd1c5f24affa14d9e1d561e54e4a&authtype=sso&custid=ns315887.